344 related articles for article (PubMed ID: 37248726)
1. Pharmacological hallmarks of allostery at the M4 muscarinic receptor elucidated through structure and dynamics.
Vuckovic Z; Wang J; Pham V; Mobbs JI; Belousoff MJ; Bhattarai A; Burger WAC; Thompson G; Yeasmin M; Nawaratne V; Leach K; van der Westhuizen ET; Khajehali E; Liang YL; Glukhova A; Wootten D; Lindsley CW; Tobin A; Sexton P; Danev R; Valant C; Miao Y; Christopoulos A; Thal DM
Elife; 2023 May; 12():. PubMed ID: 37248726
[TBL] [Abstract][Full Text] [Related]
2. Impact of species variability and 'probe-dependence' on the detection and in vivo validation of allosteric modulation at the M4 muscarinic acetylcholine receptor.
Suratman S; Leach K; Sexton P; Felder C; Loiacono R; Christopoulos A
Br J Pharmacol; 2011 Apr; 162(7):1659-70. PubMed ID: 21198541
[TBL] [Abstract][Full Text] [Related]
3. New insights into the function of M4 muscarinic acetylcholine receptors gained using a novel allosteric modulator and a DREADD (designer receptor exclusively activated by a designer drug).
Nawaratne V; Leach K; Suratman N; Loiacono RE; Felder CC; Armbruster BN; Roth BL; Sexton PM; Christopoulos A
Mol Pharmacol; 2008 Oct; 74(4):1119-31. PubMed ID: 18628403
[TBL] [Abstract][Full Text] [Related]
4. Development of a radioligand, [(3)H]LY2119620, to probe the human M(2) and M(4) muscarinic receptor allosteric binding sites.
Schober DA; Croy CH; Xiao H; Christopoulos A; Felder CC
Mol Pharmacol; 2014 Jul; 86(1):116-23. PubMed ID: 24807966
[TBL] [Abstract][Full Text] [Related]
5. Structural determinants of allosteric agonism and modulation at the M4 muscarinic acetylcholine receptor: identification of ligand-specific and global activation mechanisms.
Nawaratne V; Leach K; Felder CC; Sexton PM; Christopoulos A
J Biol Chem; 2010 Jun; 285(25):19012-21. PubMed ID: 20406819
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of action and in vivo validation of an M4 muscarinic acetylcholine receptor allosteric modulator with potential antipsychotic properties.
Leach K; Loiacono RE; Felder CC; McKinzie DL; Mogg A; Shaw DB; Sexton PM; Christopoulos A
Neuropsychopharmacology; 2010 Mar; 35(4):855-69. PubMed ID: 19940843
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and pharmacological evaluation of M4 muscarinic receptor positive allosteric modulators derived from VU10004.
Huynh T; Valant C; Crosby IT; Sexton PM; Christopoulos A; Capuano B
ACS Chem Neurosci; 2015 Jun; 6(6):838-44. PubMed ID: 25857219
[TBL] [Abstract][Full Text] [Related]
8. Xanomeline displays concomitant orthosteric and allosteric binding modes at the M
Burger WAC; Pham V; Vuckovic Z; Powers AS; Mobbs JI; Laloudakis Y; Glukhova A; Wootten D; Tobin AB; Sexton PM; Paul SM; Felder CC; Danev R; Dror RO; Christopoulos A; Valant C; Thal DM
Nat Commun; 2023 Sep; 14(1):5440. PubMed ID: 37673901
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the novel positive allosteric modulator, LY2119620, at the muscarinic M(2) and M(4) receptors.
Croy CH; Schober DA; Xiao H; Quets A; Christopoulos A; Felder CC
Mol Pharmacol; 2014 Jul; 86(1):106-15. PubMed ID: 24807965
[TBL] [Abstract][Full Text] [Related]
10. Probe dependence in the allosteric modulation of a G protein-coupled receptor: implications for detection and validation of allosteric ligand effects.
Valant C; Felder CC; Sexton PM; Christopoulos A
Mol Pharmacol; 2012 Jan; 81(1):41-52. PubMed ID: 21989256
[TBL] [Abstract][Full Text] [Related]
11. Discovery and Development of Muscarinic Acetylcholine M
Takai K; Enomoto T
Chem Pharm Bull (Tokyo); 2018; 66(1):37-44. PubMed ID: 29311510
[TBL] [Abstract][Full Text] [Related]
12. New insight into active muscarinic receptors with the novel radioagonist [³H]iperoxo.
Schrage R; Holze J; Klöckner J; Balkow A; Klause AS; Schmitz AL; De Amici M; Kostenis E; Tränkle C; Holzgrabe U; Mohr K
Biochem Pharmacol; 2014 Aug; 90(3):307-19. PubMed ID: 24863257
[TBL] [Abstract][Full Text] [Related]
13. The role of transmembrane domain 3 in the actions of orthosteric, allosteric, and atypical agonists of the M4 muscarinic acetylcholine receptor.
Leach K; Davey AE; Felder CC; Sexton PM; Christopoulos A
Mol Pharmacol; 2011 May; 79(5):855-65. PubMed ID: 21300722
[TBL] [Abstract][Full Text] [Related]
14. Probing structural requirements of positive allosteric modulators of the M4 muscarinic receptor.
Huynh T; Valant C; Crosby IT; Sexton PM; Christopoulos A; Capuano B
J Med Chem; 2013 Oct; 56(20):8196-200. PubMed ID: 24074052
[TBL] [Abstract][Full Text] [Related]
15. Role of Conserved Tyrosine Lid Residues in the Activation of the M
Pham V; Habben Jansen MCC; Thompson G; Heitman LH; Christopoulos A; Thal DM; Valant C
Mol Pharmacol; 2023 Sep; 104(3):92-104. PubMed ID: 37348914
[TBL] [Abstract][Full Text] [Related]
16. Positive allosteric modulation of M
Yohn SE; Conn PJ
Neuropharmacology; 2018 Jul; 136(Pt C):438-448. PubMed ID: 28893562
[TBL] [Abstract][Full Text] [Related]
17. Crystal structures of the M1 and M4 muscarinic acetylcholine receptors.
Thal DM; Sun B; Feng D; Nawaratne V; Leach K; Felder CC; Bures MG; Evans DA; Weis WI; Bachhawat P; Kobilka TS; Sexton PM; Kobilka BK; Christopoulos A
Nature; 2016 Mar; 531(7594):335-40. PubMed ID: 26958838
[TBL] [Abstract][Full Text] [Related]
18. Structural and dynamic insights into supra-physiological activation and allosteric modulation of a muscarinic acetylcholine receptor.
Xu J; Wang Q; Hübner H; Hu Y; Niu X; Wang H; Maeda S; Inoue A; Tao Y; Gmeiner P; Du Y; Jin C; Kobilka BK
Nat Commun; 2023 Jan; 14(1):376. PubMed ID: 36690613
[TBL] [Abstract][Full Text] [Related]
19. Allosteric modulators targeting CNS muscarinic receptors.
Bock A; Schrage R; Mohr K
Neuropharmacology; 2018 Jul; 136(Pt C):427-437. PubMed ID: 28935216
[TBL] [Abstract][Full Text] [Related]
20. Interaction studies of multiple binding sites on m4 muscarinic acetylcholine receptors.
Lanzafame AA; Sexton PM; Christopoulos A
Mol Pharmacol; 2006 Aug; 70(2):736-46. PubMed ID: 16709648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
